Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of GLP-1 Receptor Agonists on Patients With Intraductal Papillary Mucinous Neoplasms: A Retrospective Multicentric Cohort Study

NCT07014709 is registered in ClinicalTrials.gov with Hôpital Fribourgeois as lead sponsor.

NCT NCT07014709
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07014709 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of GLP-1 Receptor Agonists on Patients With Intraductal Papillary Mucinous Neoplasms: A Retrospective Multicentric Cohort Study
Lead sponsor
Hôpital Fribourgeois
Phase
Observational
Overall status
Not yet recruiting
Start date
May 31, 2025
Completion date
October 31, 2026
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glp-1, glucagon-like peptide-1 receptor agonists, intraductal papillary mucinous neoplasm of pancreas, ipmn, ipmn, pancreatic